Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, et al.. Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for Immunotherapy of Cancer, 2023, Journal for ImmunoTherapy of Cancer, 11 (11), pp.e006885. ⟨10.1136/jitc-2023-006885⟩. ⟨hal-04341909⟩

P. Pautier, A. Floquet, C. Chevreau, N. Penel, C. Guillemet, et al.. A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery. ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩. ⟨hal-03623631⟩

Antonio Di Meglio, Julie Havas, Arnauld S. Gbenou, Elise Martin, Mayssam El-Mouhebb, et al.. Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. Journal of Clinical Oncology, 2022, 40 (27), pp.3190--3204. ⟨10.1200/JCO.21.00277⟩. ⟨hal-03855946⟩

K. Zhou, M. Renouf, G. Perrocheau, N. Magné, I. Latorzeff, et al.. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT. Radiotherapy & Oncology, 2022, 173, pp.306-312. ⟨10.1016/j.radonc.2022.06.014⟩. ⟨hal-03748427⟩

T. Aparicio, O. Bouché, P. L. Etienne, E. Barbier, L. Mineur, et al.. Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial. Digestive and Liver Disease, 2023, 55 (4), pp.541-548. ⟨10.1016/j.dld.2022.08.036⟩. ⟨inserm-03986083⟩

François Quénet, Dominique Elias, Lise Roca, Diane Goéré, Laurent Ghouti, et al.. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncology, 2021, 22 (2), pp.256-266. ⟨10.1016/s1470-2045(20)30599-4⟩. ⟨hal-03220825⟩

Cécile Zinzindohoué, Pierre Bertrand, Bernard Miramand, Nicolas Sterckers, Christelle Faure, et al.. 36. Performance de la mastectomie reconstruction immédiate par grand dorsal après chimiothérapie et radiothérapie dans les carcinomes infiltrants du sein. Société Française de Sénologie et de Pathologie Mammaire - SFSPM. 35èmes Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Nov 2013, Montpellier, France. Springer, pp.341-343, 2013, Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale. ⟨hal-03580475⟩

Benjamin Morvant, Caroline Eymerit-Morin, Eric Lavoine, Franck Ah-Pine, Florence Legouté, et al.. Un polype sigmoïdien trompeur. Annales de Pathologie, 2019, 39, pp.241 - 243. ⟨10.1016/j.annpat.2019.02.012⟩. ⟨hal-03484370⟩

Frédéric Bienvenu, Benjamin Barré, Sandrine Giraud, Sylvie Avril, Olivier Coqueret. Transcriptional Regulation by a DNA-associated Form of Cyclin D1. Molecular Biology of the Cell, 2005, 16 (4), pp.1850-1858. ⟨10.1091/mbc.E04-08-0654⟩. ⟨inserm-03436440⟩

C N Montero-Menei, Laurence Sindji, Emmanuel Garcion, M Mege, D Couez, et al.. Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Research Journal, 1996, 724 (1), pp.55-66. ⟨10.1016/0006-8993(96)00268-5⟩. ⟨inserm-03436320⟩

Emilie Ernoult, Anthony Bourreau, Erick Gamelin, Catherine Guette. A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL Fractionation. BioMed Research International , 2009, 2010, pp.927917. ⟨10.1155/2010/927917⟩. ⟨hal-03388016⟩

Dorothée Duluc, Murielle Corvaisier, Simon J. Blanchard, Laurent Catala, Philippe Descamps, et al.. Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. International Journal of Cancer, 2009, 125 (2), pp.367 - 373. ⟨10.1002/ijc.24401⟩. ⟨inserm-03377765⟩

Gwenaelle Gravis, Jean-Marie Boher, Karim Fizazi, Florence Joly, Franck Priou, et al.. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model. European Urology, 2015, 68 (2), pp.196 - 204. ⟨10.1016/j.eururo.2014.09.022⟩. ⟨inserm-03353959⟩

Gwenaelle Gravis, Jean-Marie Boher, Florence Joly, Michel Soulié, Laurence Albiges, et al.. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial. European Urology, 2016, 70, pp.256 - 262. ⟨10.1016/j.eururo.2015.11.005⟩. ⟨inserm-03343628⟩

Pacôme Fosse, Sylvie Girault, Olivier Capitain, Isabelle Valo, Francis Bouchet, et al.. Apport de la TEP-FDG dans le staging initial des cancers du sein localement avancés traités par chimiothérapie néo-adjuvante. Médecine Nucléaire - Imagerie Fonctionnelle et Métabolique, 2012, 36 (2), Non spécifié. ⟨10.1016/j.mednuc.2011.11.011⟩. ⟨hal-03179503⟩

Christian Jeanguillaume, Gilles Metrard, D. Ricquier, Pierre Legras, Francis Bouchet, et al.. Visualization of Activated BAT in Mice, with FDG-PET and its relation to UCP1. Advances in Molecular Imaging, 2013, 3 (3), pp.19-22. ⟨10.4236/ami.2013.33004⟩. ⟨hal-03179486⟩

M. Roger, Anne Clavreul, Laurence Sindji, Agnès Chassevent, Paul Schiller, et al.. In vitro and in vivo interactions between glioma and marrow isolated adult multilineage inducible (MIAMI) cells.. Brain Research, 2012, 1473, pp.193-203. ⟨hal-03165478⟩

M. Caillot, J. Bourgeais, H. Dakik, É. Costé, N. Mazure, et al.. Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩. ⟨hal-02908131⟩

Jérémie Babonneau, Dimitri Bréard, Marie-Line Reynaert, Estelle Marion, David Guilet, et al.. Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters. Frontiers in Pharmacology, 2019, 10, pp.378. ⟨10.3389/fphar.2019.00378⟩. ⟨inserm-02100552⟩

Pascal Jézéquel, Delphine Loussouarn, Catherine Guérin-Charbonnel, Loïc Campion, Antoine Vanier, et al.. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Research, 2015, 17, pp.43. ⟨10.1186/s13058-015-0550-y⟩. ⟨inserm-01820311⟩